Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · IEX Real-Time Price · USD
0.428
+0.012 (2.89%)
At close: Jul 26, 2024, 3:54 PM
0.430
+0.002 (0.47%)
After-hours: Jul 26, 2024, 7:36 PM EDT

Ensysce Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Market Capitalization
33511418,67315,354
Market Cap Growth
-7.30%-30.67%-95.78%-99.39%21.62%-
Enterprise Value
02911218,676-
Last Close Price
0.791.069.001128.002984.332500.80
PE Ratio
--0.23-0.06-3.173552.78-247.00
PS Ratio
3.321.501.9132.284750.028704.12
PB Ratio
0.87-5.12-1.19-13.97-2804.47-2299.75
P/FCF Ratio
-0.55-0.31-0.27-13.83-14970.49-16416.48
P/OCF Ratio
-0.55-0.31-0.27-13.83-14970.49-16416.48
EV/Sales Ratio
2.970.853.5531.674750.60-
EV/EBITDA Ratio
---0.37-5.63-11577.56-
EV/EBIT Ratio
-0.52-0.18-0.37-5.63-11576.12-
EV/FCF Ratio
-0.49-0.18-0.50-13.57-14972.32-
Debt / Equity Ratio
0.07-1.31-1.10-2.11-0.64-0.39
Debt / FCF Ratio
-0.02-0.08-0.25-2.09-3.42-2.80
Asset Turnover
0.390.520.230.428.06-
Quick Ratio
2.140.370.360.770.030.07
Current Ratio
2.870.690.560.950.050.08
Return on Equity (ROE)
-706.87%-----
Return on Assets (ROA)
-139.06%-155.91%-135.76%-148.12%-206.67%-
Return on Capital (ROIC)
-353.77%-2204.12%-320.05%-372.49%--
Earnings Yield
-355.75%-318.25%-502.54%-25.51%0.00%-0.07%
FCF Yield
-326.02%-323.25%-371.88%-7.23%-0.01%-0.01%
Buyback Yield / Dilution
-440.17%-1158.34%-114.15%-22.15%93.11%-
Total Shareholder Return
-440.17%-1158.34%-114.15%-22.15%93.11%-
Source: S&P Capital IQ. Standard template.